Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Vaccination

NICE quality standard calls for 'timely' flu vaccination data transfer from pharmacists to GPs

The National Institute for Health and Care Excellence (NICE) has published a new quality standard (QS) for increasing uptake of flu vaccination among eligible groups of patients.

The QS emphasises the importance of sharing information on patients who have received a flu vaccine between non-GP providers and GPs.

Non-GP providers, including pharmacists, are expected to give “timely, accurate and consistent notification” to GPs, with the patient’s consent, while GPs should make “timely updates” to a patient’s record.

This will reduce unnecessary invitations and prevent inadvertent duplication of vaccinations, the standard said.

In a consultation on the draft QS, which closed on 3 September 2019, the Royal Pharmaceutical Society said that for this to happen, “there needs to be electronic processes in place that enable this to happen in a safe and effective way (e.g. from a community pharmacy to a GP practice)”.

It added that such processes are being implemented by NHS Digital and The Professional Records Standards Body, but must be “embedded into pharmacy systems to ensure ease of use”.

In October 2019, NHS Digital lauched a two-week pilot to test the digital transfer of patient flu data between 113 pharmacies and 81 GP practices in Leeds.

The QS also said providers should invite patients in a “culturally appropriate” way, taking into account patients’ literacy levels and preferred language. Providers should also consider the best way to invite under-served groups for vaccination — including people who are homeless, asylum seekers and young people leaving long-term care.

 

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2020.20207553

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.